Are dehydroepiandrosterone sulphate and lipids associated with erectile dysfunction?

Maturitas

Volumn 50, Issue 4, 2005, Pages 294-299

  Tomova, Analia ^a   Kumanov, Philip ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

DHEAS; Erectile dysfunction; Lipids; Testosterone

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGING; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; HUMAN; MALE; STATISTICAL SIGNIFICANCE;

EID: 14944384147     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.07.001     Document Type: Article

References (29)

1. NIH Consensus Conference Impotence (1993). NIH consensus development panel on impotence. JAMA 1993;270:83-90.
2. T.F. Lue Erectile dysfunction New Engl J Med 342 2000 1802 1813
3. S.Z. Qian, Y. Cheng Xu, and J. Zhang Hormonal deficiency in elderly males Int J Androl 23 Suppl 2 2000 1 3
4. S.S. Yen, and G.A. Laughlin Aging and the adrenal cortex Exp Gerontol 33 1998 897 910
5. G.A. Laughlin, and E. Barrett-Connor Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study J Clin Endocrinol Metab 85 2000 3561 3568
6. A.J. Morales, J.J. Nolan, J.C. Nelson, and S.S. Yen Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J Clin Endocrinol Metab. 78 1994 1360 1367
7. M.A. Flynn, D. Weaver-Osterholtz, K.L. Sharpe-Timms, S. Allen, and G. Krause Dehydroepiandrosterone replacement in aging humans J Clin Endocrinol Metab 84 1999 1527 1533
8. S. Legrain, C. Massien, and N. Lahlou Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects J Clin Endocrinol Metab 85 2000 3208 3217
9. D.T. Villareal, J.O. Holloszy, and W.M. Kohrt Effects of DHEA replacement on bone mineral density and body composition in elderly women and men Clin Endocrinol (Oxf) 53 2000 561 568
10. J.L. Tenover Testosterone replacement therapy in older adult men Int J Androl 22 1999 300 306
11. A. Vermeulen, S. Goemaere, and J.M. Kaufman Testosterone, body composition and aging J Endocrinol Invest 22 Suppl 5 1999 110 116
12. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, and J.B. McKinlay Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
13. P.J. Hornsby DHEA: a biologist's perspective J Am Geriatr Soc 45 1997 1395 1401
14. M.H. Kahonen, R.S. Tilvis, J. Jolkkonen, K. Pitkala, and M. Harkonen Predictors and clinical significance of declining plasma dehydroepiandrosterone sulphate in old age Aging 12 2000 308 314
15. H.A. Feldman, C.B. Johannes, A.B. Araujo, B.A. Mohr, C. Longcope, and J.B. McKinlay Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study Am J Epidemiol 153 2001 79 89
16. R.C. Rosen, A. Riley, G. Wagner, I.H. Osterloh, J. Kirkpatrick, and A. Mishra The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822 830
17. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
18. C. Longcope Dehydroepiandrosterone metabolism J Endocrinol 150 Suppl 1996 125 127
19. J.E. Morley Impotence Am J Med 80 1986 897 905
20. W. Arlt, F. Callies, and I. Koehler Dehydroepiandrosterone supplementation in healthy men with an age-releated decline of dehydroepiandrosterone secretion J Clin Endocrinol Metab 86 2001 4686 4692
21. W.J. Reiter, G. Schatzi, I. Mark, A. Zeiner, A. Pycha, and M. Marberger Dehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologies Urol Res 29 2001 278 281
22. E. Barrett-Connor, D. Kritz-Silverstein, and S.L. Edelstein A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women Am J Epidemiol 137 1993 201 206
23. L. Thijs, R. Fagard, F. Forette, T. Nawrot, and J.A. Staessen Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies Acta Cardiol 58 2003 403 410
24. I.A. Vatalas, and A. Dionyssiou-Asteriou Adrenal C19 steroids and serum lipoprotein levels in healthy men Nutr Metab Cardiovasc Dis 11 2001 388 393
25. K.T. Khaw Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease J Endocrinol 150 Suppl 1996 149 153
26. J.E. Nestler, C.O. Barlascini, J.N. Clore, and W.G. Blackard Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men J Clin Endocrinol Metab 66 1988 57 61
27. B. Srilatha, P.G. Adaikan, S.C. Ng, and S. Arulkumaran Elevated low-density lipoprotein cholesterol (LDL-C) enhances pro-erectile neurotransmission in the corpus cavernosum Int J Impot Res 11 1999 159 165
28. M. Wei, C.A. Macera, D.R. Davis, C.A. Hornung, H.R. Nankin, and S.N. Blair Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction Am J Epidemiol 140 1994 930 937
29. T. Roumeguere, E. Wespes, Y. Carpentier, P. Hoffmann, and C.C. Schulman Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk Eur Urol 44 2003 355 359